Conjugation of collagen-hybridizing peptides (CHPs) to antibody fragments can improve treatment localization to sites of denatured collagen, potentially limiting on-target effects. Check it out!
Keith’s manuscript on Fab-CHP conjugates to treat Rheumatoid Arthritis published in Bioconjugate Chemistry